Get the weekly note

ETFs that hold Neurocrine Biosciences Inc

45 US listed ETFs hold Neurocrine Biosciences Inc. PSIL holds the most, at 4.57% of the fund.

Every fund that holds it

FundNameShare of the fundHoldings filed
PSILAdvisorShares Psychedelics ETF4.57%Jun 30, 2026
IBRNiShares Neuroscience and Healthcare ETF3.72%Sep 17, 2026
PBEInvesco Biotechnology & Genome ETF2.70%Sep 19, 2026
FBTFirst Trust NYSE Arca Biotechnology Index Fund2.56%Sep 18, 2026
INVNAlger Russell Innovation ETF2.05%Jun 30, 2026
HELXFranklin Genomic Advancements ETF1.87%Jun 30, 2026
FGSIFT Vest Growth Strength & Target Income ETF1.67%Sep 18, 2026
BBHVanEck Biotech ETF1.61%Sep 17, 2026
BMEDiShares Health Innovation Active ETF1.41%Sep 17, 2026
BBPVirtus Biotech ETF1.38%Apr 30, 2026
ILDRFirst Trust Innovation Leaders ETF1.20%Sep 18, 2026
IBBiShares Biotechnology ETF1.09%Sep 17, 2026
IBBQInvesco Nasdaq Biotechnology ETF0.98%Sep 19, 2026
AGNGGlobal X Aging Population ETF0.98%Sep 18, 2026
XBIState Street SPDR S&P Biotech ETF0.90%Sep 17, 2026
QQQJInvesco NASDAQ Next Gen 100 ETF0.74%Sep 19, 2026
ABOTAbacus FCF Innovation Leaders ETF0.72%Apr 30, 2026
USMViShares MSCI USA Min Vol Factor ETF0.45%Sep 17, 2026
VBKVanguard Morningstar Small-Cap Growth ETF0.45%Aug 31, 2026
IJHiShares Core S&P Mid-Cap ETF0.44%Sep 17, 2026
MDYSPDR S&P MidCap 400 ETF Trust0.44%Sep 17, 2026
BALQiShares Nasdaq Premium Income Active ETF0.33%Sep 17, 2026
VHTVanguard Health Care ETF0.20%Aug 31, 2026
VBVanguard Morningstar Small-Cap ETF0.19%Aug 31, 2026
VXFVanguard Extended Market ETF0.18%Aug 31, 2026
FTQIFirst Trust Nasdaq BuyWrite Income ETF0.13%Sep 18, 2026
BALIiShares U.S. Large Cap Premium Income Active ETF0.12%Sep 17, 2026
ROCQJPMorgan Nasdaq Equity Premium Yield ETF0.10%Jun 30, 2026
DYNFiShares U.S. Equity Factor Rotation Active ETF0.06%Sep 17, 2026
SCHGSchwab U.S. Large-Cap Growth ETF0.06%May 31, 2026
GARPiShares MSCI USA Quality GARP ETF0.05%Sep 17, 2026
IWFiShares Russell 1000 Growth ETF0.04%Sep 17, 2026
VONGVanguard Russell 1000 Growth ETF0.04%Aug 31, 2026
ONEQFidelity Nasdaq Composite Index ETF0.03%May 31, 2026
SCHBSchwab U.S. Broad Market ETF0.02%Jun 30, 2026
SCHXSchwab U.S. Large-Cap ETF0.02%May 31, 2026
AVUSAvantis U.S. Equity ETF0.02%May 31, 2026
VTIVanguard Morningstar Total Stock Market ETF0.02%Aug 31, 2026
ITOTiShares Core S&P Total U.S. Stock Market ETF0.02%Sep 17, 2026
IWBiShares Russell 1000 ETF0.02%Sep 17, 2026
URTHiShares MSCI World ETF0.02%Sep 17, 2026
DFUSDimensional U.S. Equity Market ETF0.02%Apr 30, 2026
VTVanguard Total World Stock Index ETF0.01%Aug 31, 2026
ACWIiShares MSCI ACWI ETF0.01%Sep 17, 2026
IWDiShares Russell 1000 Value ETF0.01%Sep 17, 2026

What this counts

Neurocrine Biosciences Inc (ticker NBIX) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.

Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.

Look up another company.

Cite this page. ETFIQ, ETFs holding Neurocrine Biosciences Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/nbix/ Free to use with attribution; the underlying files are at Open data.